Effect of once-per-day tacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trial

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00293-X/fulltext?dgcid=hubspot_update_feature_updatealerts_lanres&utm_campaign=update-lanres&utm_medium=email&_hsmi=290054570&_hsenc=p2ANqtz-8EePCySKwaxo8Q5AKiTjoryREuL_j7cc9c-O9ZwS0XsSvYlVrBTSOgzhC5nLW26bDV_su0gnc94WZyEAZgG1GgZeoFGA&utm_content=289772554&utm_source=hs_email